| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows - Results suggest GLP-1 drugs ‘may have value’ in addiction treatment
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows - Results suggest GLP-1 drugs ‘may have value’ in addiction treatment
People taking semaglutide medications like Ozempic for diabetes may be at reduced risk of drug overdose, according to new research.
Prescriptions for semaglutide, which includes Ozempic and Rybelsus, were linked to lower overdose rates among patients with type 2 diabetes who were also diagnosed with opioid use disorder, according to a paper published Wednesday. (Stat News, USA, 25.09.2024)
https://www.statnews.com/2024/09/25/ozempic-rybelsus-overdose-prevention-diabetes/